Overview

Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This study will examine the effects of ondansetron on auditory nerve activity in people with schizophrenia who are being treated with new antipsychotics.
Phase:
Phase 3
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Antipsychotic Agents
Ondansetron